Back to today’s briefing

Story perspectives

NHS Launches Mounjaro for Obesity Amid GP Concerns

6/23/2025

33 6

Summary

Mounjaro Launches NHS

Starting June 23, 2023, Mounjaro, a groundbreaking weight-loss drug, will be accessible through the NHS for around 220,000 severely obese patients facing health complications. However, GPs are apprehensive about the added strain on their resources and the necessity for further training. Additionally, the Medicines and Healthcare products Regulatory Agency urges women to ensure effective contraception while using Mounjaro due to pregnancy risks.

Summary

Lilly's Weight Loss Breakthrough

Eli Lilly's groundbreaking oral weight-loss drug, orforglipron, is making waves with impressive results, matching the effectiveness of popular injectable GLP-1 medications like Ozempic and Mounjaro. In a Phase 3 trial, participants shed an average of 7.9% of their body weight. With plans to seek regulatory approval for weight management by year-end and diabetes treatment by 2026, hope is on the horizon.

1 of 2

Mounjaro Launches NHS

Starting June 23, 2023, Mounjaro, a groundbreaking weight-loss drug, will be accessible through the NHS for around 220,000 severely obese patients facing health complications. However, GPs are apprehensive about the added strain on their resources and the necessity for further training. Additionally, the Medicines and Healthcare products Regulatory Agency urges women to ensure effective contraception while using Mounjaro due to pregnancy risks.

1 / 2